Aminophylline IV Infusion Administration
Aminophylline should be administered intravenously with an initial loading dose of 5-6 mg/kg (calculated as aminophylline) given over 20-30 minutes, followed by a continuous maintenance infusion titrated based on patient age, clinical condition, and serum theophylline levels.
Loading Dose Administration
For patients not previously on theophylline:
- Administer 5.7 mg/kg aminophylline (equivalent to 4.6 mg/kg theophylline) over 20-30 minutes 1
- This typically achieves a target serum concentration of 10 mcg/mL (range 6-16 mcg/mL)
- Calculate dose based on ideal body weight, not actual weight, especially in obese patients 1
Critical caveat: If the patient has taken oral theophylline within 24 hours, do not give a full loading dose without checking serum theophylline levels first, as toxicity can occur 2. If levels cannot be measured immediately, reduce or omit the loading dose 1.
Maintenance Infusion Rates
After the loading dose, initiate continuous IV infusion at rates that vary significantly by patient population 1:
Adults (Non-smoking, otherwise healthy)
- 0.5 mg/kg/hr (as aminophylline) or 0.4 mg/kg/hr (as theophylline)
- Maximum 900 mg/day unless serum levels indicate need for higher dose
Adults with Reduced Clearance
For patients with cor pulmonale, cardiac decompensation, liver dysfunction, or taking drugs that reduce theophylline clearance (e.g., cimetidine):
- Do not exceed 21 mg/hr (as aminophylline) or 17 mg/hr (as theophylline) 1
- These patients may require 5 days to reach steady state
- More frequent monitoring is essential
Children (Age 1-9 years)
- 1.0 mg/kg/hr (as aminophylline) or 0.8 mg/kg/hr (as theophylline)
- Maximum 900 mg/day unless serum levels indicate otherwise 1
Elderly Patients (>60 years)
- Reduce dose by approximately 30% from standard adult dosing
- Theophylline clearance is significantly decreased in this population 1
Preparation and Dilution
- Aminophylline injection contains 25 mg/mL (equivalent to 19.7 mg/mL anhydrous theophylline) 1
- Dilute in 5% dextrose or normal saline for infusion
- Standard preparation: 500 mg aminophylline in 250 mL D5W 3
- Do not mix with other drugs in the same syringe 1
- Avoid mixing with alkali-labile drugs including epinephrine, norepinephrine, isoproterenol, and penicillin G potassium 1
Monitoring Requirements
Essential monitoring parameters:
- Measure serum theophylline levels at 6 and 12 hours after starting infusion to calculate clearance and adjust dosing 4
- Check levels again at 48 hours to verify therapeutic range (10-20 mcg/mL) 4
- Monitor for signs of toxicity: nausea, vomiting, tachycardia, arrhythmias, seizures
- In acute severe asthma, measure peak expiratory flow at 15-30 minutes after starting treatment 5, 6
Dosage Adjustment Based on Serum Levels
The FDA label 1 provides specific guidance for dose adjustments, though exact details require checking serum concentrations. Individual variability in theophylline clearance is substantial 2, making it impossible to achieve optimal dosing without monitoring levels.
Special Clinical Contexts
Acute Severe Asthma
In life-threatening asthma attacks, aminophylline may be considered when standard therapy fails:
- Give 250 mg IV over 20 minutes (adults) after initial bronchodilators 5, 6
- Add to nebulized β-agonists and corticosteroids
- Do not give bolus aminophylline to patients already on oral theophyllines unless levels are known 5
- Recent evidence suggests limited benefit in most pediatric cases 7, though it may reduce intubation risk in severe cases
Bradycardia (Second/Third-Degree AV Block with Acute MI)
- 250 mg IV bolus for inferior MI-associated heart block 8
Critical Safety Warnings
Aminophylline has a narrow therapeutic window. Serious adverse events occur frequently:
- Nausea and vomiting are significantly more common (RR 3.52-4.92) 7
- Risk of seizures with rapid IV administration 9
- Cardiac arrhythmias can be life-threatening
- Use infusion pump for precise rate control 10
- Inspect solution before use; discard if crystals present 1
The evidence shows that in acute asthma, aminophylline provides marginal benefit over standard therapy in adults 11 and children 7, with significant side effects. However, it may have a role in preventing intubation in severe refractory cases where mechanical ventilation appears imminent 7, 12.